Work

Abstract A039: A whole genomic CRISPR-Cas9 screen identifies the LAT3 (SLC43A1) neutral amino acid transporter as a major determinant of oxaliplatin resistance in colorectal cancer cells

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a039

Authors: Nisha R. Pawar, Heidi M. Wade, Allison V. Mitchell, Connor P. Jewell, Lisa M. Jenkins, Robert W. Robey, Michael M. Gottesman

Institution: National Cancer Institute

Language: English

Topic: Amino Acid Enzymes and Metabolism

Subfield: Biochemistry

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444565

Cites:

Cited by:

Related to: